ResMed

San Diego, United States Founded: 1989 • Age: 37 yrs Listed
Therapeutic devices to treat sleep apnea and respiratory disorders

About ResMed

ResMed is a publicly listed company based in San Diego (United States) founded in 1989 by Peter Farrell. The company has 10,600 employees. ResMed has completed 15 acquisitions, including BiancaMed, Brightree and Curative Medical. Its website resmed.com draws about 2.9 million monthly visits. Its Indian entity Resmed India Private Limited reported revenue of ₹268 Cr. ResMed offers products and services including CPAP Devices, CPAP Masks, and myAir App. Its focus areas include Life Sciences, Sleep Medicine, Medical Device and Therapeutics. Its competitors include ProSomnus, AeroCare Holdings and Sommetrics; 3 of its 3 listed competitors have raised funding.

Company details

Therapeutic devices to treat sleep apnea and respiratory disorders. The companys products include Masks (Nasal pillows, Nasal masks, Full-face masks, Paediatric masks, and Non-vented masks), Devices (Range of CPAP, VPAP, Ventilators, etc), Humidifiers, and Accessories. The company developed a non-contact sleep tracking system that helps users analyze and improve sleep. The system records the light, noise, and temperature conditions in the room, and syncs with smartphones to provide feedback and suggestions. In 2022, the company recorded annual revenues of 4.02B and a net profit of 0.86B

  • Headquarters San Diego, United States
  • Employees 10,600
  • Founders Peter Farrell
  • Stage Public
  • Sectors
    Healthcare
  • Website category Health
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website resmed.com/en-us
  • Social LinkedIn X Facebook Instagram YouTube
  • Legal Name Resmed Inc.
Operational Areas
Key Metrics
  • Indian entity revenue
    ₹268 Cr

    FY 2025 · +15% YoY

  • Indian entity net profit
    ₹7.74 Cr

    FY 2025 · 3% margin

  • Indian entity EBITDA
    ₹13.00 Cr

    FY 2025 · 5% margin

  • Latest Funding Round
    $500M (USD), Debt – Conventional

    Jul 2019

  • Investors
  • Employee Count
    10,600
  • Investments & Acquisitions
    BiancaMed

    & 14 more

Products & Services of ResMed

ResMed offers a comprehensive portfolio of products and services, including CPAP Devices, CPAP Masks, and myAir App.

CPAP Devices
Sleep Therapy

Devices that deliver continuous positive airway pressure for sleep apnoea treatment.

CPAP Masks
Medical Accessories

Masks designed for secure fit during CPAP therapy sessions.

myAir App
Digital Health

App for monitoring and managing patient therapy progress remotely.

Apps and channels of ResMed

ResMed publishes 4 mobile apps with over 1.1M+ downloads; its YouTube channel Resmed UK has 54.7K subscribers and 30 videos.

AirMini™ by ResMed
Google Play Medical Everyone Free
Developer: ResMed
View on Google Play
myAir™ by Resmed
Google Play Medical Everyone Free
Developer: ResMed
View on Google Play
AirMini™ by ResMed
App Store Medical 12+
Developer: ResMed
View on App Store
myAir™ by Resmed
App Store Medical 12+
Developer: ResMed
View on App Store
Resmed UK
YouTube 54.7K subscribers 30 videos Science & Technology
Open channel

Videos from ResMed

The most watched videos on ResMed's YouTube channel, Resmed UK (54.7K subscribers). Click a video to play it here.

ResMed - How CPAP therapy improved my quality of life
1.6K views
ResMed - Give yourself time to get used to treatment
974 views
30 Years of ResMed
812 views
ResMed - Coming up for Air, Nick’s story from symptoms, to diagnosis and treatment
565 views

More on Resmed UK.

Funding Insights of ResMed

  • Total Rounds 2
  • Last Round Debt – Conventional — $500M
  • Investors Count 1

All 2 funding rounds of ResMed with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jul 2019$500MDebt – Conventional––
–
Oct 2016Post-IPO––
Valuation history

1 investors in total: 1 institutional.

Investors in ResMed

ResMed has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Mirrabooka Investments.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
SME foused PE firm investing in Australia and New Zealand
1999mirra.com.auMelbourne, Australia
Premium access

Investor details for ResMed

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Resmed India Private Limited (ResMed)

Resmed India Private Limited is the primary company behind ResMed. The board of Resmed India Private Limited currently have 3 directors; the longest-serving is Ashish Kumar Matta, appointed in 2017. 13 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Ashish Kumar Matta
DIN 07890861
Director26 Jul 20179 yrs 3 moResmed India Private Limited
Michael James Rider
DIN 10242127
Director28 Jul 20233 yrs 3 moResmed India Private Limited
Sandeep Gulati
DIN 10580373
Director15 Apr 20242 yrs 6 moResmed India Private Limited

People of ResMed

663 people are tracked at ResMed (198 in leadership, 5 in board & advisors, 460 in team); the tracked headcount is 10,600.

NameRoleGroup
Peter Farrell
FounderLeadership
Justin Leong
Chief Product OfficerLeadership
Carlos M. Nunez
Chief Medical OfficerLeadership
Luong Phung
Director, Technical Program Management, Digital SolutionsLeadership
Katrina Arey
Vice President, Global Marketing Operations And Chief Of StaffLeadership
Leonie Heddo
Head Of Executive And Leadership Development (global)Leadership
Claude London
Vice President, Corporate StrategyLeadership
Jonathan Gale
Global Head Of Talent ManagementLeadership
Denise Hartsell
Director, Commercial TransformationLeadership
Nick Knowlton
Vice President, Strategic InitiativesLeadership
Vivek Dabholkar
Director - Software Engineering - IntegrationsLeadership
Jeff Otsuji
Senior Director Sales OperationsLeadership
Natalie Pacholl
People Team Chief Of Staff And Transformation Office Project ManagerLeadership
Yan Zhang
Sr. People Business Partner-chinaLeadership
Bridger Mecham
Senior Director Of MarketingLeadership
Stephen Panetta
Senior Director - Fp&a Systems And AnalyticsLeadership
Gary Storey
Lead Talent Sourcing Partner, North America And EuropeLeadership
Jin Ming S.
Commercial Controller / Finance Business PartnerLeadership
Gerardo Ferrero
B4b Head LatamLeadership
Rishabh Singh
Talent acquisition PartnerLeadership

643 more people are available in the full profile.

Premium access

Complete people profiles for ResMed

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of ResMed

ResMed is a publicly listed company on the NYSE with ticker symbol RMD in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date25 Mar 2020
  • Listed onB3: R1MD34
  • Listed entityResMed Inc.
  • Exchange sectorHealth technology
  • ISINUS7611521078
  • Share price$235.04 (+0.19% on the day) · 2026-10-13
  • Market capitalisation$33.06B
  • Price to earnings22.5
  • EPS (diluted, trailing year)$10.44
  • Dividend yield1.05%
  • Volume (last session)892,026

Financials of ResMed

Figures of Resmed India Private Limited, the primary company behind ResMed, for FY 2025. Revenue was ₹268 Cr (+15% year on year). Net profit was ₹7.74 Cr (3% margin). EBITDA was ₹13.00 Cr (5% margin). Revenue has grown at a compounded annual rate of -3% over three years and +24% over five years.

  • ₹268 CrRevenue · FY 2025 · +15% YoY
  • ₹7.74 CrNet profit · 3% margin
  • ₹13.00 CrEBITDA · 5% margin
  • ₹4.49 CrPaid-up capital
  • 65Employees (provident fund records)
  • -3%Revenue CAGR, 3 years
  • +24%Revenue CAGR, 5 years
Exchange-reported annual figures
YearRevenueNet incomeEBITDA
2026$5.65B$1.52B$2.17B
2025$5.15B$1.40B$1.92B
2024$4.69B$1.02B$1.60B
2023$4.22B$897.6M$1.35B
2022$3.58B$779.4M$1.19B

Balance sheet, profit and loss, cash flow and ratios of Resmed India Private Limited are on its company page.

Premium access

Detailed financial statements for ResMed

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by ResMed

ResMed has strategically engaged in corporate development activities, having acquired 15 companies. Notable acquisitions include BiancaMed, Brightree and Curative Medical.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Overnight oximetry devices and diagnostic devices for sleep and respiratory disorder monitoring
virtuox.netCoral Springs, United States2005May 2025••••
Provides a care management digital platform which enables patients to be cared for outside of hospital wall.
inhealthcare.co.ukHarrogate, United Kingdom2012Jun 2024••••
Integrated care delivery and analytics platform for sleep disorder management
somnoware.comSunnyvale, United States2013Jul 2023••••
Insomnia treatment is provided online via the Somnio application.
mementor.deGermany0Aug 2022••••
Provider of connected solutions for monitoring sleep disorders
ectosense.comLeuven, Belgium2015Oct 2021••••
Mobile platform and a sensor for respiratory health management
propellerhealth.comMadison, United States2010Dec 2018$225M
Web-based software for long term care, senior living, and assisted living
matrixcare.comBloomington, United States1982Nov 2018$750M
Cloud-based software and services are offered for home health providers.
healthcarefirst.comSpringfield, United States1992May 2018••••
Cloud-based solutions are delivered to the home care sector.
brightree.comPeachtree Corners, United States2002Feb 2016$800M
Oxygen concentrators are designed and manufactured for respiratory patients.
inovalabs.comAustin, United States2002Jan 2016••••
Premium access

Complete acquisition details for ResMed

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of ResMed

14 dated milestones of ResMed across 36 years, from founding to its latest funding, stage changes and deals.

  1. Founded ResMed is founded.
  2. Acquisition Acquires Inova Labs.
  3. Acquisition Acquires Brightree.
  4. Funding First funding round.
  5. Acquisition Acquires HEALTHCAREfirst.
  6. Acquisition Acquires MatrixCare.
  7. Acquisition Acquires Propeller Health.
  8. Funding Latest funding round, Debt – Conventional, of $500.0M.
  9. IPO Lists on the stock exchange (IPO).
  10. Acquisition Acquires Ectosense.
  11. Acquisition Acquires mementor GmbH.
  12. Acquisition Acquires Somnoware.
  13. Acquisition Acquires Inhealthcare.
  14. Acquisition Acquires VirtuOx.

Competitors of ResMed

ResMed has 3 listed competitors in our database, 3 of them funded. They include ProSomnus, AeroCare Holdings and Sommetrics.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
prosomnus.com2016Dublin, United States$12.68M125
Lower jaw advancement devices for obstructive sleep apnea are developed.
aerocareusa.com2002Orlando, United States$1M2,688
Provider of medical devices for obstructive respiratory diseases and sleep apnea
sommetrics.com2007San Diego, United States$31.1M16
Sommetrics is focused on diagnosing, treating and monitoring Obstructive Sleep Effect.
Premium access

Detailed competitors of ResMed

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of ResMed

The website of ResMed (resmed.com) receives about 2.9M visits a month and ranks #18,358 among all websites worldwide, #382 in Health.

  • Monthly visits
    2.9M

    ▼ 1.5% vs previous month

  • Unique visitors
    850.3K

    per month

  • Global rank
    #18,358

    among all websites

  • Category rank
    #382

    Health · Health

Similar websites

Websites whose visitors overlap most with ResMed. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
cpap.com
100%
467.6K#85,509View details
thecpapshop.com
91%
680.7K#122,146View details
easybreathe.com
easybreathe.com
74%
#191,325–
respironics.com
70%
6K#3,213,822View details
cpapsupplyusa.com
69%
#752,005View details
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 40 similar websites and full traffic analytics for ResMed

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Sleep Medicine

3 companies that operate in the same segment as ResMed (Sleep Medicine) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Smart baby monitors and sleep tracking solutions are provided.
2014New York, New York, United StatesUSD 116.6 M
Devices and apps for snoring and sleep-disordered breathing are provided.
2015Needham, Massachusetts, United StatesUSD 57.15 M
Sleep diagnostics and monitoring solutions are provided by Onera Health.
2018Palo Alto, California, United StatesUSD 65.02 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Resmed

Premium access

Complete news archive for ResMed

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about ResMed

ResMed was founded in 1989 and raised its 1st funding round 27 years after it was founded.

ResMed is headquartered in San Diego, United States. It is registered at San Diego, California, United States.

ResMed has 10,600 employees.

The primary company behind ResMed, Resmed India Private Limited, reported revenue of ₹268 Cr for FY 2025, up 15% year on year.

Therapeutic devices to treat sleep apnea and respiratory disorders. The companys products include Masks (Nasal pillows, Nasal masks, Full-face masks, Paediatric masks, and Non-vented masks), Devices (Range of CPAP, VPAP, Ventilators, etc), Humidifiers, and Accessories. The company developed a non-contact sleep tracking system that helps users analyze and improve sleep. The system records the light, noise, and temperature conditions in the room, and syncs with smartphones to provide feedback and suggestions. In 2022, the company recorded annual revenues of 4.02B and a net profit of 0.86B.

ResMed's top competitors include ProSomnus, AeroCare Holdings and Sommetrics.

ResMed offers CPAP Devices, CPAP Masks, and myAir App.

Yes, ResMed is publicly traded on NYSE under the ticker symbol RMD.

ResMed has made 15 acquisitions, including BiancaMed, Brightree, and Curative Medical.

ResMed has 1 investor. Key investors include Mirrabooka Investments.

ResMed operates through Resmed India Private Limited.

The legal entities of ResMed currently have 3 directors, including Ashish Kumar Matta, Sandeep Gulati, Michael James Rider.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available